PROVIDENT BANCORP INC (PVBC)

US74383L1052 - Common Stock

11.86  -0.11 (-0.92%)

After market: 11.86 0 (0%)

Fundamental Rating

3

PVBC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 407 industry peers in the Banks industry. While PVBC seems to be doing ok healthwise, there are quite some concerns on its profitability. PVBC does not seem to be growing, but still is valued expensively.



2

1. Profitability

1.1 Basic Checks

PVBC had positive earnings in the past year.
PVBC had a positive operating cash flow in the past year.
Of the past 5 years PVBC 4 years were profitable.
Each year in the past 5 years PVBC had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.83%, PVBC is in line with its industry, outperforming 49.39% of the companies in the same industry.
PVBC's Return On Equity of 6.09% is on the low side compared to the rest of the industry. PVBC is outperformed by 70.52% of its industry peers.
Industry RankSector Rank
ROA 0.83%
ROE 6.09%
ROIC N/A
ROA(3y)0.09%
ROA(5y)0.41%
ROE(3y)0.5%
ROE(5y)2.25%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PVBC's Profit Margin of 22.56% is in line compared to the rest of the industry. PVBC outperforms 46.93% of its industry peers.
PVBC's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for PVBC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 22.56%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.69%
PM growth 5Y-5.76%
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

PVBC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PVBC remains at a similar level compared to 1 year ago.
Compared to 5 years ago, PVBC has less shares outstanding
PVBC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

There is no outstanding debt for PVBC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC13.03%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 154.90% over the past year.
The Earnings Per Share has been growing slightly by 5.71% on average over the past years.
The Revenue for PVBC has decreased by -23.09% in the past year. This is quite bad
PVBC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.57% yearly.
EPS 1Y (TTM)154.9%
EPS 3Y0%
EPS 5Y5.71%
EPS Q2Q%130.77%
Revenue 1Y (TTM)-23.09%
Revenue growth 3Y3.99%
Revenue growth 5Y9.57%
Sales Q2Q%-13.4%

3.2 Future

The Earnings Per Share is expected to decrease by -15.41% on average over the next years. This is quite bad
The Revenue is expected to decrease by -2.63% on average over the next years.
EPS Next Y-23.88%
EPS Next 2Y-15.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-12.67%
Revenue Next 2Y-2.63%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.12 indicates a correct valuation of PVBC.
Based on the Price/Earnings ratio, PVBC is valued a bit more expensive than 61.67% of the companies in the same industry.
When comparing the Price/Earnings ratio of PVBC to the average of the S&P500 Index (24.41), we can say PVBC is valued slightly cheaper.
With a Price/Forward Earnings ratio of 24.74, PVBC is valued on the expensive side.
Based on the Price/Forward Earnings ratio, PVBC is valued a bit more expensive than 78.62% of the companies in the same industry.
PVBC's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 20.59.
Industry RankSector Rank
PE 14.12
Fwd PE 24.74

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, PVBC is valued expensively inside the industry as 80.10% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF 36.44
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as PVBC's earnings are expected to decrease with -15.41% in the coming years.
PEG (NY)N/A
PEG (5Y)2.47
EPS Next 2Y-15.41%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PVBC!.
Industry RankSector Rank
Dividend Yield N/A

PROVIDENT BANCORP INC

NASDAQ:PVBC (7/26/2024, 7:00:01 PM)

After market: 11.86 0 (0%)

11.86

-0.11 (-0.92%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap209.45M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 14.12
Fwd PE 24.74
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)2.47
Profitability
Industry RankSector Rank
ROA 0.83%
ROE 6.09%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 22.56%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)154.9%
EPS 3Y0%
EPS 5Y
EPS Q2Q%
EPS Next Y-23.88%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-23.09%
Revenue growth 3Y3.99%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y